Study of Renal Accumulation of Targeted Polycations in Acute Kidney Injury

Weimin Tang1, Sudipta Panja1, Chinmay M Jogdeo1

  • 1Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.

Biomacromolecules
|April 8, 2022
PubMed

Insights

Researchers developed novel polymeric plerixafor analogs to improve drug delivery for acute kidney injury (AKI). Modifications in charge and hydrophilicity influenced kidney accumulation, guiding future targeted AKI therapies.

Area of Science:

  • Biomaterials Science
  • Renal Pharmacology
  • Drug Delivery Systems

Background:

  • Acute kidney injury (AKI) presents a significant global health challenge with high mortality rates.
  • Chemokine receptor CXCR4 is implicated in immune cell infiltration and inflammation in AKI.
  • Overexpression of CXCR4 on injured renal tubule cells offers a potential therapeutic target for AKI.

Purpose of the Study:

  • To synthesize and characterize polymeric plerixafor (PP) copolymers with varying charge and hydrophilicity.
  • To evaluate the impact of polymer properties on CXCR4 binding, cellular uptake, and renal accumulation in AKI models.
  • To guide the development of advanced polymeric drug carriers for targeted AKI treatment.

Main Methods:

  • Synthesis of PP copolymers with hydroxyl, carboxyl, primary amine, and alkyl groups via Michael-type addition copolymerization.
  • In vitro assessment of CXCR4 binding affinity and inhibition, and cellular uptake in stimulated mouse tubule cells.
  • In vivo biodistribution studies in a unilateral ischemia-reperfusion-induced AKI mouse model.

Main Results:

  • All synthesized copolymers demonstrated potent in vitro CXCR4 antagonism and enhanced cellular uptake in kidney tubule cells.
  • Polymers modified with hydroxyl groups exhibited minimal serum protein binding.
  • Significant variations in polymer accumulation within injured kidneys were observed, correlating with net charge and hydrophilicity.

Conclusions:

  • The study successfully developed novel polymeric CXCR4 antagonists with tunable properties for AKI.
  • Polymer charge and hydrophilicity are critical determinants for effective renal accumulation and targeted drug delivery in AKI.
  • These findings provide a foundation for designing next-generation polymeric drug carriers for enhanced AKI therapeutics.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
69
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
56
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
130
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
106
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
127
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
83